rosiglitazone has been researched along with Crohn Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caruso, R; Gao, F; Head, RD; Holtzman, MJ; Kaiko, GE; Kern, JT; Liu, TC; McGovern, DP; Nunez, G; Rajala, MW; Stappenbeck, TS; VanDussen, KL; Wilen, CB; Xiong, S | 1 |
| Benight, N; Denson, LA; Frank, SJ; Han, X; Loesch, K; Osuntokun, B | 1 |
| Blumberg, RS; Nakajima, A; Wada, K | 1 |
3 other study(ies) available for rosiglitazone and Crohn Disease
| Article | Year |
|---|---|
Interaction between smoking and ATG16L1T300A triggers Paneth cell defects in Crohn's disease.
Topics: Animals; Apoptosis; Autophagy-Related Proteins; Carrier Proteins; Crohn Disease; Female; Genetic Predisposition to Disease; Humans; Male; Mice; Mice, Knockout; Mutation, Missense; Paneth Cells; PPAR gamma; Rosiglitazone; Smoking | 2018 |
Signal transducer and activator of transcription 5b promotes mucosal tolerance in pediatric Crohn's disease and murine colitis.
Topics: Animals; Carrier Proteins; Child; Colitis; Colon; Crohn Disease; Epithelial Cells; Female; Genetic Predisposition to Disease; Humans; Hypoglycemic Agents; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; Mucous Membrane; NF-kappa B; PPAR gamma; Rosiglitazone; Signal Transduction; STAT5 Transcription Factor; Thiazolidinediones; Trinitrobenzenesulfonic Acid | 2006 |
PPARgamma and inflammatory bowel disease: a new therapeutic target for ulcerative colitis and Crohn's disease.
Topics: Animals; Anti-Inflammatory Agents; Chromans; Colitis, Ulcerative; Crohn Disease; Disease Models, Animal; Inflammation; Intestines; Ligands; Mice; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 2001 |